Filing Details
- Accession Number:
- 0001209191-22-056573
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-14 16:11:48
- Reporting Period:
- 2022-11-11
- Accepted Time:
- 2022-11-14 16:11:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1253689 | Glycomimetics Inc | GLYC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1589713 | L. John Magnani | C/O Glycomimetics, Inc. 9708 Medical Center Drive Rockville MD 20850 | Svp Of Research, Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-11-11 | 45,045 | $1.17 | 366,078 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 4,845 | Indirect | By GlycoTech Corporation |
Footnotes
- The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.10 to $1.20 per share, with a weighted average purchase price of $1.17 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- These shares are held by GlycoTech Corporation, of which the reporting person is the sole stockholder.